CN103088433B - 全基因组甲基化高通量测序文库的构建方法及其应用 - Google Patents
全基因组甲基化高通量测序文库的构建方法及其应用 Download PDFInfo
- Publication number
- CN103088433B CN103088433B CN201110342351.7A CN201110342351A CN103088433B CN 103088433 B CN103088433 B CN 103088433B CN 201110342351 A CN201110342351 A CN 201110342351A CN 103088433 B CN103088433 B CN 103088433B
- Authority
- CN
- China
- Prior art keywords
- fragment
- dna
- methylation
- genome
- sequencing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000011987 methylation Effects 0.000 title claims abstract description 139
- 238000007069 methylation reaction Methods 0.000 title claims abstract description 139
- 238000012165 high-throughput sequencing Methods 0.000 title claims abstract description 84
- 238000010276 construction Methods 0.000 title abstract description 12
- 239000012634 fragment Substances 0.000 claims abstract description 118
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 55
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims abstract description 22
- 238000012408 PCR amplification Methods 0.000 claims abstract description 19
- 230000003321 amplification Effects 0.000 claims abstract description 16
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 16
- 230000008439 repair process Effects 0.000 claims abstract description 13
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims abstract description 10
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940035893 uracil Drugs 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 83
- 238000012163 sequencing technique Methods 0.000 claims description 63
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- 238000007405 data analysis Methods 0.000 claims description 14
- 238000000746 purification Methods 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- VYLDEYYOISNGST-UHFFFAOYSA-N bissulfosuccinimidyl suberate Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)C(S(O)(=O)=O)CC1=O VYLDEYYOISNGST-UHFFFAOYSA-N 0.000 claims description 10
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 6
- 108010006785 Taq Polymerase Proteins 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 238000001962 electrophoresis Methods 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 230000001035 methylating effect Effects 0.000 claims description 3
- 102000012410 DNA Ligases Human genes 0.000 claims description 2
- 108010061982 DNA Ligases Proteins 0.000 claims description 2
- 108010017826 DNA Polymerase I Proteins 0.000 claims description 2
- 102000004594 DNA Polymerase I Human genes 0.000 claims description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 claims description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 claims description 2
- 239000011324 bead Substances 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 108010068698 spleen exonuclease Proteins 0.000 claims description 2
- 239000011543 agarose gel Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 230000029087 digestion Effects 0.000 abstract description 10
- 108020004414 DNA Proteins 0.000 description 116
- 239000000523 sample Substances 0.000 description 47
- 238000001976 enzyme digestion Methods 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 29
- 238000001514 detection method Methods 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 238000005516 engineering process Methods 0.000 description 17
- 108091029430 CpG site Proteins 0.000 description 15
- 108091029523 CpG island Proteins 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000012149 elution buffer Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000012148 binding buffer Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- CTMZLDSMFCVUNX-VMIOUTBZSA-N cytidylyl-(3'->5')-guanosine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(N=C(N)N3)=O)N=C2)O)[C@@H](CO)O1 CTMZLDSMFCVUNX-VMIOUTBZSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 230000007067 DNA methylation Effects 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 2
- 108700025695 Suppressor Genes Proteins 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000001369 bisulfite sequencing Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- 108091061939 Selfish DNA Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000011278 co-treatment Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 230000019975 dosage compensation by inactivation of X chromosome Effects 0.000 description 1
- 230000009109 downstream regulation Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007608 epigenetic mechanism Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (31)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110342351.7A CN103088433B (zh) | 2011-11-02 | 2011-11-02 | 全基因组甲基化高通量测序文库的构建方法及其应用 |
PCT/CN2012/083821 WO2013064066A1 (zh) | 2011-11-02 | 2012-10-31 | 全基因组甲基化高通量测序文库的构建方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110342351.7A CN103088433B (zh) | 2011-11-02 | 2011-11-02 | 全基因组甲基化高通量测序文库的构建方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103088433A CN103088433A (zh) | 2013-05-08 |
CN103088433B true CN103088433B (zh) | 2014-09-24 |
Family
ID=48191334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110342351.7A Active CN103088433B (zh) | 2011-11-02 | 2011-11-02 | 全基因组甲基化高通量测序文库的构建方法及其应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103088433B (zh) |
WO (1) | WO2013064066A1 (zh) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10023856B2 (en) * | 2013-09-25 | 2018-07-17 | Thermo Fisher Scientific Baltics Uab | Enzyme composition for DNA end repair, adenylation, phosphorylation |
CN104611410A (zh) * | 2013-11-04 | 2015-05-13 | 北京贝瑞和康生物技术有限公司 | 一种无创癌症检测方法及其试剂盒 |
CN103555856B (zh) * | 2013-11-15 | 2015-02-11 | 复旦大学 | 一种全基因组dna甲基化的导向测序技术 |
WO2016082057A1 (zh) * | 2014-11-25 | 2016-06-02 | 深圳华大基因研究院 | 游离dna测序文库的构建方法 |
CN104532360B (zh) * | 2014-12-17 | 2017-02-22 | 北京诺禾致源科技股份有限公司 | 全基因组甲基化测序文库及其构建方法 |
CN104480214B (zh) * | 2014-12-30 | 2018-01-16 | 深圳市易基因科技有限公司 | 羟甲基化暨甲基化长序列标签测序技术 |
CN104694635B (zh) * | 2015-02-12 | 2017-10-10 | 北京百迈客生物科技有限公司 | 一种高通量简化基因组测序文库的构建方法 |
CN104946623A (zh) * | 2015-04-08 | 2015-09-30 | 浙江圣庭生物科技有限公司 | 基于Illumina Hiseq 2500测序平台的小片段DNA文库的构建方法 |
CN105002567B (zh) * | 2015-06-30 | 2017-10-13 | 北京百迈客生物科技有限公司 | 无参考基因组高通量简化甲基化测序文库的构建方法 |
CN106435744B (zh) * | 2015-08-13 | 2022-02-01 | 生捷科技控股公司 | 使用y-接头和消失限制位点的文库构建 |
CN105274629B (zh) * | 2015-11-17 | 2017-11-17 | 安诺优达基因科技(北京)有限公司 | 简化的表观重亚硫酸氢盐测序用文库的构建方法及试剂盒 |
CN105506109A (zh) * | 2015-12-31 | 2016-04-20 | 安诺优达基因科技(北京)有限公司 | 一种单细胞简化代表性重亚硫酸氢盐测序的方法及试剂盒 |
CN106283198B (zh) * | 2015-12-31 | 2021-08-13 | 浙江安诺优达生物科技有限公司 | 用于单细胞全基因组重亚硫酸氢盐测序的文库构建方法 |
US11053542B2 (en) * | 2015-12-31 | 2021-07-06 | Quest Diagnostics Investments Llc | Compositions and methods for screening mutations in thyroid cancer |
CN105986030A (zh) * | 2016-02-03 | 2016-10-05 | 广州市基准医疗有限责任公司 | 甲基化dna检测方法 |
CN106701939A (zh) * | 2016-12-22 | 2017-05-24 | 中国热带农业科学院热带生物技术研究所 | 一种胞嘧啶甲基化挖掘的方法 |
CN106980774A (zh) * | 2017-03-29 | 2017-07-25 | 电子科技大学 | 一种dna甲基化芯片数据的扩展方法 |
CN107190003A (zh) * | 2017-06-09 | 2017-09-22 | 武汉天问生物科技有限公司 | 一种高效快速分离t‑dna***位点侧翼序列的方法及其用途 |
US20200160936A1 (en) * | 2017-06-28 | 2020-05-21 | Icahn School Of Medicine At Mount Sinai | Methods for high-resolution microbiome analysis |
CN107460238A (zh) * | 2017-07-07 | 2017-12-12 | 沈阳宁沪科技有限公司 | 一种无创高通量甲基化***癌诊断、研究和治疗方法 |
CN107451419B (zh) * | 2017-07-14 | 2020-01-24 | 浙江大学 | 通过计算机程序模拟产生简化dna甲基化测序数据的方法 |
CN107541791A (zh) * | 2017-10-26 | 2018-01-05 | 中国科学院北京基因组研究所 | 血浆游离dna甲基化检测文库的构建方法、试剂盒及应用 |
CN108034705A (zh) * | 2018-01-15 | 2018-05-15 | 武汉爱基百客生物科技有限公司 | 一种全基因组甲基化高通量测序方法 |
CN108251504A (zh) * | 2018-01-17 | 2018-07-06 | 翌圣生物科技(上海)有限公司 | 一种超快速构建基因组dna测序文库的方法和试剂盒 |
CN108753923A (zh) * | 2018-06-04 | 2018-11-06 | 广州微芯生物科技有限公司 | 一种构建甲基化测序文库的方法及相应的接头序列和试剂盒 |
CN108866155B (zh) * | 2018-06-11 | 2022-07-26 | 中国农业科学院深圳农业基因组研究所 | 一种下一代测序文库的制备方法 |
CN109402285A (zh) * | 2018-11-09 | 2019-03-01 | 北京林业大学 | 一种基于全基因组dna甲基化位点基因型的分型方法 |
CN109943628A (zh) * | 2018-12-11 | 2019-06-28 | 北京中科遗传与生殖医学研究院有限责任公司 | 利用DedscRRBS分析法对活检细胞进行PGS及甲基化分析的方法 |
WO2020135347A1 (zh) * | 2018-12-29 | 2020-07-02 | 深圳华大生命科学研究院 | 一种dna甲基化检测的方法、试剂盒、装置和应用 |
CN109629009B (zh) * | 2019-01-10 | 2022-02-22 | 北京中科遗传与生殖医学研究院有限责任公司 | 一种基于RAD-seq对胚胎进行无创PGS的方法 |
WO2020232621A1 (zh) * | 2019-05-21 | 2020-11-26 | 深圳华大智造科技有限公司 | 微量dna甲基化高通量测序方法 |
CN116043337A (zh) * | 2019-08-27 | 2023-05-02 | 江苏鹍远生物科技股份有限公司 | Dna甲基化标志物筛查试剂盒及方法 |
CN110669824A (zh) * | 2019-10-11 | 2020-01-10 | 广州迈森致远基因科技有限公司 | 低起始量血浆游离dna甲基化建库试剂盒及方法 |
CN110820050A (zh) * | 2019-11-22 | 2020-02-21 | 北京吉因加科技有限公司 | 全基因组甲基化非重亚硫酸氢盐测序文库及构建 |
CN111575347A (zh) * | 2020-05-19 | 2020-08-25 | 清华大学 | 构建用于同时获得血浆中游离dna甲基化和片段化模式信息的文库的方法 |
CN112126987A (zh) * | 2020-08-19 | 2020-12-25 | 深圳思凝一云科技有限公司 | 一种用于甲基化扩增子测序的建库方法 |
CN112779320B (zh) * | 2020-12-04 | 2023-07-14 | 深圳市易基因科技有限公司 | 多区域dna甲基化检测探针设计及其检测方法 |
CN113421608B (zh) * | 2021-07-03 | 2023-12-01 | 南京世和基因生物技术股份有限公司 | 肝癌早筛模型的构建方法、检测装置以及计算机可读取介质 |
CN113604540B (zh) * | 2021-07-23 | 2022-08-16 | 杭州圣庭医疗科技有限公司 | 一种利用血液循环肿瘤dna快速构建rrbs测序文库的方法 |
CN113550013B (zh) * | 2021-07-23 | 2022-11-01 | 杭州圣庭医疗科技有限公司 | 一种利用***固定石蜡包埋样本快速构建rrbs测序文库的方法 |
CN114045342A (zh) * | 2021-12-01 | 2022-02-15 | 大连晶泰生物技术有限公司 | 一种游离DNA(cfDNA)甲基化突变的检测方法及试剂盒 |
CN114480576B (zh) * | 2022-01-26 | 2023-04-07 | 纳昂达(南京)生物科技有限公司 | 靶向甲基化测序文库的构建方法及试剂盒 |
CN114507737A (zh) * | 2022-03-22 | 2022-05-17 | 杭州医学院 | 一种石棉相关疾病甲基化标记物的检测引物组合、试剂盒及扩增子测序文库的构建方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101979545A (zh) * | 2010-11-12 | 2011-02-23 | 深圳华大基因科技有限公司 | 一种用于定向克隆的核苷酸序列及载体 |
CN102533944A (zh) * | 2010-12-10 | 2012-07-04 | 深圳华大基因科技有限公司 | 用于甲基化dna的富集和测序的半甲基化接头及其用途 |
-
2011
- 2011-11-02 CN CN201110342351.7A patent/CN103088433B/zh active Active
-
2012
- 2012-10-31 WO PCT/CN2012/083821 patent/WO2013064066A1/zh active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101979545A (zh) * | 2010-11-12 | 2011-02-23 | 深圳华大基因科技有限公司 | 一种用于定向克隆的核苷酸序列及载体 |
CN102533944A (zh) * | 2010-12-10 | 2012-07-04 | 深圳华大基因科技有限公司 | 用于甲基化dna的富集和测序的半甲基化接头及其用途 |
Non-Patent Citations (4)
Title |
---|
GU, H. ET AL..Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling.《NATURE PROTOCOLS》.2011,第6卷(第4期), |
High-throughput bisulfite sequencing in mammalian genomes;SMITH, Z.D. ET AL;《METHODS》;20090731;第48卷(第3期);第226-232页 * |
Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling;GU, H. ET AL.;《NATURE PROTOCOLS》;20110317;第6卷(第4期);第468-481页 * |
SMITH, Z.D. ET AL.High-throughput bisulfite sequencing in mammalian genomes.《METHODS》.2009,第48卷(第3期), |
Also Published As
Publication number | Publication date |
---|---|
WO2013064066A1 (zh) | 2013-05-10 |
CN103088433A (zh) | 2013-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103088433B (zh) | 全基因组甲基化高通量测序文库的构建方法及其应用 | |
CN108699598B (zh) | 用于分析修饰的核苷酸的组合物和方法 | |
US9518295B2 (en) | High-throughput sequencing method for methylated DNA and use thereof | |
CN106906211B (zh) | 一种分子接头及其应用 | |
CN113661249A (zh) | 用于分离无细胞dna的组合物和方法 | |
CN110734908A (zh) | 高通量测序文库的构建方法以及用于文库构建的试剂盒 | |
CN109536579B (zh) | 单链测序文库的构建方法及其应用 | |
EP3885445B1 (en) | Methods of attaching adapters to sample nucleic acids | |
CN109576346B (zh) | 高通量测序文库的构建方法及其应用 | |
CN110628880B (zh) | 一种同步使用信使rna与基因组dna模板检测基因变异的方法 | |
JP2010535513A (ja) | 高スループット亜硫酸水素dnaシークエンシングのための方法および組成物ならびに有用性 | |
CN105986015B (zh) | 一种基于高通量测序的多样本的一个或多个靶序列的检测方法和试剂盒 | |
WO2012068919A1 (zh) | DNA文库及其制备方法、以及检测SNPs的方法和装置 | |
CN113668068B (zh) | 基因组甲基化文库及其制备方法和应用 | |
CN113969307A (zh) | Dna甲基化测序文库及制备方法和dna甲基化检测方法 | |
CN112941635A (zh) | 一种提高文库转化率的二代测序建库试剂盒及其方法 | |
CN108624666B (zh) | 用于构建测序文库的接头核酸分子 | |
CN109825552B (zh) | 一种用于对目标区域进行富集的引物及方法 | |
CN111575349B (zh) | 一种接头序列及其应用 | |
CN109136217B (zh) | 一种测序文库构建的方法、建库试剂及其应用 | |
CN113604540A (zh) | 一种利用血液循环肿瘤dna快速构建rrbs测序文库的方法 | |
CN109234388B (zh) | 用于dna高甲基化区域富集的试剂、富集方法及应用 | |
WO2022199242A1 (zh) | 一组条码接头以及中通量多重单细胞代表性dna甲基化建库和测序方法 | |
CN112080555A (zh) | Dna甲基化检测试剂盒及检测方法 | |
CN107794573B (zh) | 一种构建dna大片段文库的方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BGI-SHENZHEN Effective date: 20130717 Owner name: BGI TECHNOLOGY SOLUTIONS CO., LTD. Free format text: FORMER OWNER: BGI-SHENZHEN CO., LTD. Effective date: 20130717 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130717 Address after: 518083 science and Technology Pioneer Park, comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, Shenzhen 201 Applicant after: BGI Technology Solutions Co., Ltd. Address before: North Road No. 146, building 11F-3 Industrial Zone in Yantian District of Shenzhen city of Guangdong Province in 518083 Applicant before: BGI-Shenzhen Co., Ltd. Applicant before: BGI-Shenzhen |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1183699 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1183699 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160727 Address after: 300308, Tianjin free trade zone (Airport Economic Zone) ring River Road, 80, airport business park, 201-1 East Building, room 3 Patentee after: Tianjin Huada medical laboratory Co., Ltd. Address before: Science and Technology Pioneer Park, comprehensive building, Beishan Industrial Zone, Yantian District, Guangdong, Shenzhen 201, China Patentee before: BGI Technology Solutions Co., Ltd. |